| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = -$18,487 ) |
| | 2026 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K99AR082989 | Mechanobiology of fracture healing during skeletal disuse | 000 | 2 | NIH | 11/20/2025 | -$18,487 |
|
| Issue Date FY: 2025 ( Subtotal = $132,490,624 ) (Continued on the next page) |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AI078958 | Understanding Unique Aspects of Motility and Chemotaxis in Borrelia burgdorferi | 000 | 14 | NIH | 3/19/2025 | $473,229 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA259599 | Interplay between tumor and microenvironment in bone metastasis | 001 | 5 | NIH | 5/22/2025 | $47,095 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA063061 | Vulnerability to Substance Use: Transitions and Trajectories in ABCD Youth with Validation Using Longitudinal Twin Family Samples | 001 | 1 | NIH | 7/24/2025 | $122,288 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA063061 | Vulnerability to Substance Use: Transitions and Trajectories in ABCD Youth with Validation Using Longitudinal Twin Family Samples | 000 | 1 | NIH | 6/30/2025 | $598,475 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R25AA027402 | Guided Research Experiences and Applied Training (GREAT) in Alcohol Studies | 002 | 7 | NIH | 8/18/2025 | $118,398 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AR082365 | Unraveling the Mechanism of Mechanotransduction in Hierarchical Collagen Fiber Formation | 001 | 3 | NIH | 5/15/2025 | $23,340 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA259599 | Interplay between tumor and microenvironment in bone metastasis | 000 | 5 | NIH | 3/17/2025 | $423,861 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AR082365 | Unraveling the Mechanism of Mechanotransduction in Hierarchical Collagen Fiber Formation | 000 | 3 | NIH | 2/14/2025 | $300,078 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AA020912 | 4/11 Neuroimmune and extracellular matrix interactions in alcohol consumption | 000 | 15 | NIH | 3/4/2025 | $384,244 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AA020912 | 4/11 Neuroimmune and extracellular matrix interactions in alcohol consumption | 001 | 15 | NIH | 8/4/2025 | $42,694 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01FD006071 | Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal) | 001 | 3 | FDA | 2/24/2025 | $398,302 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01FD006071 | Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal) | 003 | 5 | FDA | 6/9/2025 | $398,302 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01FD006071 | Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal) | 002 | 2 | FDA | 5/21/2025 | $398,302 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AI167857 | Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesis | 000 | 4 | NIH | 1/28/2025 | $555,206 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01MH124981 | Developmental methylomics of autism spectrum disorder | 000 | 5 | NIH | 2/13/2025 | $585,546 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R34CA286879 | Investigating Feasibility and Acceptability of the FearLess Protocol for Patients with Primary Malignant Brain Tumors and Their Caregivers | 001 | 2 | NIH | 9/2/2025 | $288,940 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK142965 | Integrating a Prescription Produce Program within a Diabetes Prevention Program for the Prevention of Type 2 Diabetes | 000 | 1 | NIH | 9/12/2025 | $931,500 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG3DA063353 | Novel 5-HT2A/mGluR5 Antagonist for Opioid Use Disorder | 000 | 1 | NIH | 9/2/2025 | $1,153,945 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | H79TI086367 | Community Collaborative Partnership for First Responders Addiction and Recovery Training Consortium | 001 | 3 | SAMHSA | 9/25/2025 | $1,594,430 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG3DA062112 | Psilocybin-Assisted Treatment of Cocaine Use Disorder | 000 | 1 | NIH | 7/7/2025 | $643,019 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA061265 | A mechanistic study of the role of the orexin system and insomnia within a buprenorphine opioid use disorder treatment sample | 001 | 1 | NIH | 9/15/2025 | $0 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA061265 | A mechanistic study of the role of the orexin system and insomnia within a buprenorphine opioid use disorder treatment sample | 000 | 1 | NIH | 7/11/2025 | $465,669 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA058089 | Reprogramming KZFP function to understand drug-specific transcription and behavior | 001 | 2 | NIH | 4/10/2025 | $52,468 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA058089 | Reprogramming KZFP function to understand drug-specific transcription and behavior | 000 | 2 | NIH | 2/28/2025 | $472,214 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HD112416 | A Hospital-based Intervention for Youth Injured through Violence | 000 | 1 | NIH | 8/6/2025 | $659,863 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01NS138169 | A Longitudinal Evaluation of Psychophysiological and Motor Dysfunction following Concussion: Associations with Subsequent Injury | 000 | 1 | NIH | 7/8/2025 | $483,673 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R33AG081939 | Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias | 000 | 3 | NIH | 8/6/2025 | $578,913 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30HD118818 | Implications of Epigenetic Regulation in Congenital Myotonic Dystrophy through Development | 000 | 1 | NIH | 8/20/2025 | $45,988 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01GM160681 | C18-Ceramide as an essential factor in iron dependent cell death | 000 | 1 | NIH | 9/10/2025 | $115,326 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01GM160681 | C18-Ceramide as an essential factor in iron dependent cell death | 000 | 1 | NIH | 9/10/2025 | $208,311 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01GM160681 | C18-Ceramide as an essential factor in iron dependent cell death | 000 | 1 | NIH | 9/10/2025 | $113,809 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG3EY036558 | Fenofibrate microemulsion for treating nitrogen mustard induced corneal injury | 000 | 1 | NIH | 9/10/2025 | $547,902 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG3EY036558 | Fenofibrate microemulsion for treating nitrogen mustard induced corneal injury | 000 | 1 | NIH | 9/10/2025 | $22,677 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R00AA030611 | Dissecting the co-occurrence of alcohol use/problems and suicidal behaviors: the roles of genetic liability and neurocognitive mechanisms | 000 | 3 | NIH | 9/11/2025 | $248,999 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K08DK140618 | The transcription factor RUNX1 is pivotal in TGFβ-activated cholangiocyte signaling with the immune system in biliary fibrosis | 000 | 1 | NIH | 9/11/2025 | $176,094 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K23DK141991 | Advancing sacral neuromodulation with objective analytics and prediction | 000 | 1 | NIH | 8/29/2025 | $177,350 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31HL176081 | Hydrogen Sulfide for the Prevention of Cisplatin-Induced Atherosclerosis | 000 | 1 | NIH | 8/14/2025 | $46,494 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R00HL169903 | Mechanotransduction regulation of cellular metabolism in pulmonary fibrosis | 000 | 3 | NIH | 7/30/2025 | $248,999 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3NS133630 | Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus | 000 | 3 | NIH | 8/28/2025 | $653,216 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | DP1DA063098 | Novel Mu Opioid Receptor Modulators to Counteract Synthetic Opioids | 000 | 1 | NIH | 8/25/2025 | $465,750 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DE033686 | Exploiting immunostimulatory microbial pattern recognition to improve head and neck cancer therapy | 000 | 1 | NIH | 8/12/2025 | $427,208 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA272147 | Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms | 000 | 3 | NIH | 3/6/2025 | $563,791 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA272147 | Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms | 001 | 3 | NIH | 5/22/2025 | $62,643 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R35GM158247 | Genetic code expansion to improve the drug-likeness of hits from mRNA display | 000 | 1 | NIH | 8/1/2025 | $378,899 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K99CA296217 | Clarifying the relationship between air pollution and lung and breast cancer with a spatial data science approach | 000 | 1 | NIH | 7/31/2025 | $107,633 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AG082251 | Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study | 001 | 3 | NIH | 6/10/2025 | $48,988 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AG082251 | Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study | 000 | 3 | NIH | 3/20/2025 | $551,124 |
|
